Active Ingredient: NILOTINIB TARTRATE
Proprietary Name: DANZITEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 95MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N219293
Product Number: 002
Approval Date: Nov 7, 2024
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
